← Leaderboards
Lars Eckmann
University Of California San Diego
$20,489,190
Attributed
$24,217,630
Total exposure
22
Grants
21
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$32,647,067 · 23
By mechanism
P30$9,666,485 · 3
R01$8,889,100 · 4
U01$4,872,406 · 1
P01$2,152,173 · 4
R21$2,024,133 · 5
R24$1,545,000 · 1
Top collaborators
- Bernd G. Schnabl8 shared
- Anthony John O'Donoghue7 shared
- Liangfang Zhang6 shared
- Valery V Fokin2 shared
- Rohit Loomba1 shared
- David H Peyton1 shared
Most similar at University Of California San Diego
Same institution · by research overlap
- Sharon L Reed$12,983,856
- Robert C Rickert$18,269,835
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionDesignBaseIntestinesMouse ModelPathogenCellsInnovationResearch PersonnelInflammationAnimal ModelIn VitroIn VivoInsightAntimicrobialParasitesProgramsMetronidazoleLeadEnteric PathogenResistanceServicesSurfaceDigestive System Disorders
Grant awards (76)
San Diego Digestive Diseases Research Center$1,190,951
P30 · FY2025 · DK
Proteasome inhibitors against mucosal protozoan pathogens$648,435
R01 · FY2025 · AI · contact PI
Multidisciplinary Research Training in Digestive Physiology and Diseases$373,088
T32 · FY2025 · DK · contact PI
Pilot and Feasibility Program$180,828
P30 · FY2025 · DK · contact PI
San Diego Digestive Diseases Research Center$1,205,451
P30 · FY2024 · DK
Proteasome inhibitors against mucosal protozoan pathogens$648,435
R01 · FY2024 · AI · contact PI
Pilot and Feasibility Program$180,828
P30 · FY2024 · DK · contact PI
San Diego Digestive Diseases Research Center$1,184,550
P30 · FY2023 · DK
Proteasome inhibitors against mucosal protozoan pathogens$648,435
R01 · FY2023 · AI · contact PI
Pilot and Feasibility Program$176,375
P30 · FY2023 · DK · contact PI
San Diego Digestive Diseases Research Center$1,184,670
P30 · FY2022 · DK
Proteasome inhibitors against mucosal protozoan pathogens$648,435
R01 · FY2022 · AI · contact PI
Membrane-cloaked nanoparticles as mucosal vaccines against giardiasis$197,500
R21 · FY2022 · AI · contact PI
Pilot and Feasibility Program$176,375
P30 · FY2022 · DK · contact PI
San Diego Digestive Diseases Research Center$1,184,080
P30 · FY2021 · DK
Proteasome inhibitors against mucosal protozoan pathogens$648,435
R01 · FY2021 · AI · contact PI
Membrane-cloaked nanoparticles as mucosal vaccines against giardiasis$237,000
R21 · FY2021 · AI · contact PI
Pilot and Feasibility Program$176,283
P30 · FY2021 · DK · contact PI
San Diego Digestive Diseases Research Center$1,145,710
P30 · FY2020 · DK
Nanoparticle decoys for treating infections with enterotoxin-producing pathogens$450,673
R33 · FY2020 · AI · contact PI
Selective proteasome inhibitors for trichomoniasis$196,875
R21 · FY2020 · AI · contact PI
Pilot and Feasibility Program$170,542
P30 · FY2020 · DK · contact PI
San Diego Digestive Diseases Research Center$152,775
P30 · FY2020 · DK
San Diego Digestive Diseases Research Center$1,181,250
P30 · FY2019 · DK
Next-generation 5-nitro heterocyclic antimicrobials against mucosal protists$623,681
R01 · FY2019 · AI · contact PI
Nanoparticle decoys for treating infections with enterotoxin-producing pathogens$450,673
R33 · FY2019 · AI · contact PI
Selective proteasome inhibitors for trichomoniasis$236,250
R21 · FY2019 · AI · contact PI
Pilot and Feasibility Program$175,817
P30 · FY2019 · DK · contact PI
Next-generation 5-nitro heterocyclic antimicrobials against mucosal protists$623,681
R01 · FY2018 · AI · contact PI
Nanoparticle decoys for treating infections with enterotoxin-producing pathogens$450,673
R33 · FY2018 · AI · contact PI
Next-generation 5-nitro heterocyclic antimicrobials against mucosal protists$623,681
R01 · FY2017 · AI · contact PI
Next-generation 5-nitro heterocyclic antimicrobials against mucosal protists$623,681
R01 · FY2016 · AI · contact PI
High-potency nitro antimicrobials for topical treatment of trichomoniasis$353,902
R41 · FY2016 · AI
Nanoparticle decoys for treating infections with enterotoxin-producing pathogens$306,459
R21 · FY2016 · AI · contact PI
Protective antigens of Giardia lamblia$232,500
R21 · FY2016 · AI · contact PI
Gold Compounds for the Topical Treatment of Trichomoniasis$113,799
R21 · FY2016 · AI · contact PI
Next-generation 5-nitro heterocyclic antimicrobials against mucosal protists$637,431
R01 · FY2015 · AI · contact PI
Gold Compounds for the Topical Treatment of Trichomoniasis$310,000
R21 · FY2015 · AI · contact PI
Protective antigens of Giardia lamblia$193,750
R21 · FY2015 · AI · contact PI
Mucosal Responses to Minimally Invasive Pathogens$213,194
P01 · FY2013 · DK · contact PI
Mouse Model Core$151,049
P01 · FY2013 · DK · contact PI
The UCSD Digestive Diseases Research Development Center$502,125
R24 · FY2012 · DK · contact PI
Mucosal Responses to Minimally Invasive Pathogens$219,752
P01 · FY2012 · DK · contact PI
Mouse Model Core$157,606
P01 · FY2012 · DK · contact PI
Next-generation 5-nitroimidazoles against giardiasis$1,036,268
U01 · FY2011 · AI · contact PI
The UCSD Digestive Diseases Research Development Center$502,125
R24 · FY2011 · DK · contact PI
Mucosal Responses to Minimally Invasive Pathogens$189,195
P01 · FY2011 · DK · contact PI
Mouse Model Core$127,049
P01 · FY2011 · DK · contact PI
Next-generation 5-nitroimidazoles against giardiasis$953,513
U01 · FY2010 · AI · contact PI
The UCSD Digestive Diseases Research Development Center$540,750
R24 · FY2010 · DK · contact PI
Click chemistry for novel antimicrobials against periodontal pathogens$476,202
RC1 · FY2010 · DE · contact PI
MUTANT NOD2 IN INTESTINAL INFLAMMATION AND HOST DISEASE$238,699
R01 · FY2010 · DK · contact PI
Mucosal Responses to Minimally Invasive Pathogens$191,105
P01 · FY2010 · DK · contact PI
Mouse Model Core$128,333
P01 · FY2010 · DK · contact PI
Next-generation 5-nitroimidazoles against giardiasis$910,179
U01 · FY2009 · AI · contact PI
Click chemistry for novel antimicrobials against periodontal pathogens$485,410
RC1 · FY2009 · DE · contact PI
Mutant NOD2 in Intestinal Inflammation and Host Defense$241,111
R01 · FY2009 · DK · contact PI
Mucosal Responses to Minimally Invasive Pathogens$231,571
P01 · FY2009 · DK · contact PI
Mouse Model Core$155,507
P01 · FY2009 · DK · contact PI
Next-generation 5-nitroimidazoles against giardiasis$977,645
U01 · FY2008 · AI · contact PI
Mutant NOD2 in Intestinal Inflammation and Host Defense$241,111
R01 · FY2008 · DK · contact PI
MOUSE MODELS OF INTESTINAL INFECTION AND INFLAMMATION$96,914
K26 · FY2008 · RR · contact PI
Next-generation 5-nitroimidazoles against giardiasis$994,801
U01 · FY2007 · AI · contact PI
HOST DEFENSES AGAINST PATHOGENIC E. coli$288,247
R01 · FY2007 · AI · contact PI
Mutant NOD2 in Intestinal Inflammation and Host Defense$246,032
R01 · FY2007 · DK · contact PI
Mouse Model Core$202,201
P01 · FY2007 · DK · contact PI
Mucosal Responses to Minimally Invasive Pathogens$185,611
P01 · FY2007 · DK · contact PI
MOUSE MODELS OF INTESTINAL INFECTION AND INFLAMMATION$94,090
K26 · FY2007 · RR · contact PI
HOST DEFENSES AGAINST PATHOGENIC E. coli$296,856
R01 · FY2006 · AI · contact PI
MUTANT NOD2 IN INTESTINAL INFLAMMATION AND HOST DISEASE$253,380
R01 · FY2006 · DK · contact PI
MOUSE MODELS OF INTESTINAL INFECTION AND INFLAMMATION$91,350
K26 · FY2006 · RR · contact PI
HOST DEFENSES AGAINST PATHOGENIC E. coli$304,000
R01 · FY2005 · AI
MOUSE MODELS OF INTESTINAL INFECTION AND INFLAMMATION$88,689
K26 · FY2005 · RR
HOST DEFENSES AGAINST PATHOGENIC E. coli$304,000
R01 · FY2004 · AI
MOUSE MODELS OF INTESTINAL INFECTION AND INFLAMMATION$86,106
K26 · FY2004 · RR
HOST DEFENSES AGAINST PATHOGENIC E. coli$101,334
R01 · FY2003 · AI